Mymetics Corp (MYMX)

[Harry Wickey]

The market surely does not think so.

I am a bit perplexed that the stock has not shown a substantial increase. (maybe an opportunity to double up, I might) The study was designed to fail and it didn't until it reached a viral load that was so high the vaccine could not stop the infection. The potential for this vaccine is ground breaking IMO. Searching through other attempts there is nothing close to this and it does not use live virus (in vaccine). I think they should have talked more about the makeup of vaccine in the news release. Some inside buying would be a good sign...

I do not think that peer review has happened at this time because the study needs to be published first. But coming out of a very prestigious institute and top researcher it should get published.

The debt of the company and the ability of Round Enterprises to convert debt to shares could be an issue. But the 60-70mm is nothing if they have an HIV vaccine.

This link shows the possible global market for and HIV vaccine. http://www.ncbi.nlm.nih.gov/pubmed/20471439 it should be higher because its a 6 year old study.
60 million debt is a drop in the bucket compared to market for this vaccine.